Correction: Synthesis and structure−activity relationships of DCLK1 kinase inhibitors based on a 5,11-dihydro‑6H‑benzo[e]pyrimido[5,4‑b][1,4]diazepin-6-one Scaffold (Journal of Medical Chemistry (2020) 63:14 (7817−7826) DOI: 10.1021/acs.jmedchem.0c00596)

Fleur M. Ferguson, Yan Liu, Wayne Harshbarger, Ling Huang, Jinhua Wang, Xianming Deng, Stephen J. Capuzzi, Eugene N. Muratov, Alexander Tropsha, Senthil Muthuswamy, Kenneth D. Westover, Nathanael S. Gray

Radiation Oncology
Biochemistry
Radiation Oncology - Administration

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Correction: Synthesis and structure−activity relationships of DCLK1 kinase inhibitors based on a 5,11-dihydro‑6H‑benzo[e]pyrimido[5,4‑b][1,4]diazepin-6-one Scaffold (Journal of Medical Chemistry (2020) 63:14 (7817−7826) DOI: 10.1021/acs.jmedchem.0c00596)'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Correction: Synthesis and structure−activity relationships of DCLK1 kinase inhibitors based on a 5,11-dihydro‑6H‑benzo[e]pyrimido[5,4‑b][1,4]diazepin-6-one Scaffold (Journal of Medical Chemistry (2020) 63:14 (7817−7826) DOI: 10.1021/acs.jmedchem.0c00596)

Fingerprint

Chemical Compounds

Medicine & Life Sciences